Oncology Today with Dr Neil Love
Oncology Today with Dr Neil Love
✓

Diffuse Large B-Cell Lymphoma — A Grand Rounds Program

· یادداشت ها را نشان دهید
01:01:39
Podcasts
RSS
Link

درباره این اپیزود

Featuring a presentation by Dr Matthew Matasar, including the following topics:

  • Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00)
  • Clinician Survey Results Regarding First-Line Treatment of DLBCL (11:41)
  • Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL (16:01)
  • Clinician Survey Results Regarding the Use of Monoclonal and Bispecific Antibodies for R/R DLBCL (28:47)
  • Evidence-Based Incorporation of Antibody-Drug Conjugates (ADCs) into the Management of R/R DLBCL (34:34)
  • Clinician Survey Results Regarding the Use of ADCs for R/R DLBCL (46:31)
  • Discussion of Questions from the Community (50:20)

CME information and select publications

پزشکی
تحصیل
سلامتی و تناسب اندام
پزشکی
علوم پایه
انگلیسی
ایالات متحده آمریکا
ازAPIبرای واکشی این قسمت درJSONاستفاده کنید

در این اپیزود

این برچسب‌ها را ویرایش کنید

یادداشت ها را نشان دهید 🔗

00:00:00Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
00:11:41Clinician Survey Results Regarding First-Line Treatment of DLBCL
00:16:01Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL
00:28:47Clinician Survey Results Regarding the Use of Monoclonal and Bispecific Antibodies for R/R DLBCL
00:34:34Evidence-Based Incorporation of Antibody-Drug Conjugates (ADCs) into the Management of R/R DLBCL
00:46:31Clinician Survey Results Regarding the Use of ADCs for R/R DLBCL
00:50:20Discussion of Questions from the Community

رونوشت 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

جستجوی اپیزودهای گذشته

اپیزودهای قبلی Oncology Today with Dr Neil Love را جستجو کن.
این نوار جستجو را در وب سایت خود قرار دهید

قسمت های دیگر در این پادکست

Prostate Cancer — An Interview with Prof Karim Fizazi

Prostate Cancer — An Interview with Prof Karim Fizazi

Featuring an interview with Prof Karim Fizazi, including the following topics: Perspectives on the PROTEUS Phase III trial evaluating the addition of apalutamide to standard therapy for high-risk localized prostate cancer (0:00) Mechanism of action of opevesostat and potential role in castration-r…
01:01:31
همحخوان کردن
ذخیره
Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 3

Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 3

Featuring perspectives from Prof Susana Banerjee, including the following topics: Overview of the biology and treatment of low-grade serous ovarian cancer (0:00) Mechanism of action of avutometinib/defactinib (10:16) RAMP 201 Trial: Avutometinib/defactinib in recurrent low-grade serous ovarian can…
00:32:19
همحخوان کردن
ذخیره
Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome

Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome

Featuring perspectives from Dr Spencer Bachow, Dr Bhavana (Tina) Bhatnagar, Dr Jennifer Crombie, Dr Manali Kamdar and Ms Alexandra Lynch, co-moderated by Dr Bachow and Dr Bhatnagar, including the following topics: Introduction and Overview of Bispecific Antibodies in the Clinic (0:00) Current and …
01:58:22
همحخوان کردن
ذخیره
Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 4

Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 4

Featuring perspectives from Prof Susana Banerjee, including the following topics: Case: A woman in her mid 50s with multiregimen-recurrent low-grade serous ovarian cancer and a KRAS G12V mutation who receives avutometinib/defactinib with response, asymptomatic creatine phosphokinase elevation and …
00:28:10
همحخوان کردن
ذخیره
Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

Featuring a slide presentation from Dr Julia Rotow, including the following topics: Rationale and potential clinical role of PD-1/PD-L1 x vascular endothelial growth factor (VEGF) bispecific antibodies in the treatment of non-small cell lung cancer (NSCLC) (0:00) Key findings from the Phase III HA…
00:24:03
همحخوان کردن
ذخیره
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Dr. Neil Love است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
PROMOTED
The best Podcast API & MCP to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API & MCP to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

پیشنهادها
از API برای دریافت این اپیزود استفاده کنید